Mind Cure Health Inc.
CA$0.08CA$0.00 (0.0%)
Mind Cure Health Inc.’s quoted price sits in the upper half of its reported 52-week range, 16.67% below the high.
CNQ · ASEP.CN · CAD
Stock price, earnings
Quote as of Oct 28, 2026, 08:44 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
Asep Medical Holdings Inc’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Asep Medical Holdings Inc’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Asep Medical Holdings Inc. is dedicated to advancing medical solutions, primarily through its subsidiary, ASEP Medical Inc. The company's core focus involves pioneering an early diagnostic method for Sepsis, as well as developing innovative peptide-based therapeutic treatments applicable to a variety of medical conditions. Established in 2020, this Vancouver, Canada-based firm was formerly known as Trenchant Life Sciences Investment Corp. before adopting its present identity.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:30 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$0.08CA$0.00 (0.0%)
Mind Cure Health Inc.’s quoted price sits in the upper half of its reported 52-week range, 16.67% below the high.
CA$0.02CA$0.00 (0.0%)
SQI Diagnostics Inc.’s quoted price sits in the lower half of its reported 52-week range, 91.67% below the high.
CA$0.06CA$0.00 (0.0%)
Tryp Therapeutics Inc.: Healthcare · Biotechnology.
CA$0.04+CA$0.01 (+16.67%)
Willow Biosciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 95.17% below the high.
CA$0.12CA$0.00 (0.0%)
GeneTether Therapeutics Inc.: Healthcare · Biotechnology.
$5.85+$0.00 (+0.03%)
Clearmind Medicine Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.78% below the high.
CA$0.10-CA$0.04 (-25.93%)
Awakn Life Sciences Corp.: Healthcare · Biotechnology.
$0.00$0.00 (0.0%)
StageZero Life Sciences Ltd.’s quoted price sits in the lower half of its reported 52-week range, 91.45% below the high.